Inhalable vaccine for COVID-19 a step closer
2 years, 9 months ago

Inhalable vaccine for COVID-19 a step closer

China Daily  

A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's branch office building in Shanghai, China, Feb 25, 2022. An inhaled COVID-19 vaccine developed by CanSino Biologics has entered late-stage clinical trials, with data suggesting it is eligible to apply for emergency use in China, the company's chief scientist said. Zhu said clinical data shows that the inhaled vaccine is safe and can deliver broad protection against the novel coronavirus that causes COVID-19, including its mutated strains. As respiratory viruses typically target the lungs and upper airways, an inhaled vaccine can bolster the immune response in cells that form the mucous membrane in those parts of the body, serving as the first line of defense against the pathogen, Zhu said. "The inhaled version only uses about one-fifth of the dosage of a conventional injection," Zhu said, making it much easier to administer and more accessible to people around the globe.

China Vaccines Vaccine Zhu Inhaled  inhalable  making  zhu  vaccines  immune  inhaled  step  covid19  closer  vaccine  upper  response  respiratory

History of this topic

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

China approves its first mRNA vaccine for Covid-19
1 year, 9 months ago

China approves its first mRNA vaccine for Covid-19

Hindustan Times  

China has approved its first locally developed messenger RNA vaccine against Covid-19, its manufacturer said Wednesday, months after the relaxation of strict Covid-zero regulations sparked a surge in cases. China Covid: mRNA vaccines are considered among the most effective in reducing severe infections and deaths. mRNA vaccines are considered among the most effective in reducing severe infections and deaths. While …

COVID-19 update: China faces challenge due to flawed containment policies, ineffective vaccines, says Report
1 year, 10 months ago

COVID-19 update: China faces challenge due to flawed containment policies, ineffective vaccines, says Report

India TV News  

China COVID-19 update : China is facing a significant challenge in the form of COVID-19, due to the Chinese Communist Party's "flawed and regressive containment policies and ineffective domestically produced vaccines," GeoPolitica.info reported. China's COVID-19 containment strategy has affected Chinese people and has caused major discontent among people in the country, as per the GeoPolitica.info report. Vaccines manufactured in China …

Six fallacies and truths about China's epidemic control
1 year, 11 months ago

Six fallacies and truths about China's epidemic control

China Daily  

A community worker explains a COVID-19 prevention and care package to a resident in Yangfangdian Subdistrict of Haidian District in Beijing, Dec 27, 2022. China has also optimized the circulation of drugs, testing reagents and protective goods for better epidemic control. By the middle of December 2022, more than 3.47 billion COVID-19 vaccine doses had been administered on the Chinese …

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy
1 year, 11 months ago

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy

News 18  

A sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, has successfully been isolated by India to assess the efficacy of available vaccines. “Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,” a source was quoted as saying. India has reported at least four …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

China sees nearly 37 million new Covid cases in one single day, says report
1 year, 11 months ago

China sees nearly 37 million new Covid cases in one single day, says report

India TV News  

China Covid Wave: China, which is going through its worst phase of the Covid pandemic so far, reported nearly 37 million new infections in a day this week, ANI cited UK-based Financial Times report. Meanwhile, a leaked document, purportedly from China's National Health Commission, said around 248 million, roughly 17.56 per cent of the total population were affected by the …

Explained | What is the threat from global COVID-19 rise?
2 years ago

Explained | What is the threat from global COVID-19 rise?

The Hindu  

The story so far: The Union Ministry of Health has issued a communique to States to resume genome sequencing of new cases of COVID-19, in view of the sudden spurt of cases in some parts of the world. In a letter, Union Health Secretary Rajesh Bhushan said sequencing of positive case samples will allow the Indian SARS-CoV-2 Genomics Consortium network …

OPINION | Covid threat: India is on a stronger wicket compared to China, says Dr Guleria
2 years ago

OPINION | Covid threat: India is on a stronger wicket compared to China, says Dr Guleria

India TV News  

As scary visuals come in from China of bodies of Covid-19 victims being laid out inside containers, the Centre and state governments have revved up arrangements to ensure full preparedness in the face of fresh challenge. In my prime time show Aaj Ki Baat on Friday night, we showed fresh videos and pictures of large number of Covid patients undergoing …

Explained: Are Chinese vaccines to blame for its COVID-19 surge?
2 years ago

Explained: Are Chinese vaccines to blame for its COVID-19 surge?

Firstpost  

China’s homemade vaccines are far less efficient against COVID-19 than the Western-made mRNA vaccines. This, as Beijing has exported its vaccines to over 40 countries including Pakistan, Zimbabwe, Cambodia and Philippines China’s COVID-19 surge has set the world on edge. The Western mRNA vaccines order the body’s cells to build a replica of a key coronavirus protein to trigger an …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

WHO chief ‘very concerned’ over COVID situation in China
2 years ago

WHO chief ‘very concerned’ over COVID situation in China

Al Jazeera  

China could be struggling to keep a tally of COVID-19 infections as the country experiences a big spike in cases, a senior World Health Organization official has said, amid concerns about a lack of data from the country. “In China, what’s been reported is relatively low numbers of cases in ICUs, but anecdotally ICUs are filling up,” WHO’s emergencies director …

Fact-check on vaccine-related misinformation
2 years ago

Fact-check on vaccine-related misinformation

China Daily  

Vaccine is a powerful weapon in the fight against COVID-19. As the second COVID booster becomes available for eligible people and the health authorities work to boost senior vaccination rates, misinformation about COVID-19 vaccines is also rising. The COVID-19 vaccines work by imitating an infection and can cause mild side effects, such as a fever or pain at the injection …

Fact-check on vaccine-related misinformation
2 years ago

Fact-check on vaccine-related misinformation

China Daily  

Vaccine is a powerful weapon in the fight against COVID-19. As the second COVID booster becomes available for eligible people and the health authorities work to boost senior vaccination rates, misinformation about COVID-19 vaccines is also rising. The COVID-19 vaccines work by imitating an infection and can cause mild side effects, such as a fever or pain at the injection …

Inhalable COVID-19 vaccinations available in Shandong
2 years ago

Inhalable COVID-19 vaccinations available in Shandong

China Daily  

A needle-free COVID-19 vaccination with a sweet twist is now available in many cities in Shandong province, such as Jining, Qingdao, Zaozhuang and Jinan, and people who fear needles or appreciate convenience have rushed to vaccination centers to get their inhalable vaccinations. A poster for inhalable COVID-19 vaccinations The dose is administered via a cup containing the aerosol of the …

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use
2 years ago

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use

Live Mint  

World's first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation for restricted use in emergency situations in the age group of 18 and above. A press release from the vaccine maker said iNCOVACC, a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein, is the world's first …

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity
2 years, 1 month ago

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity

The Independent  

Cancer drugs worked better after patients had had Covid-19 jabs, scientists have discovered. Patients with nasopharyngeal cancer – in the area from the back of the nose to the upper part of the throat – who had had a coronavirus vaccine “responded significantly better” to treatment than unvaccinated patients, according to German and Chinese experts. They were surprised when the …

China launches a COVID-19 vaccine inhaled through the mouth
2 years, 1 month ago

China launches a COVID-19 vaccine inhaled through the mouth

The Hindu  

The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first. A video posted by an online Chinese state media outlet showed people at a community health center sticking the short nozzle of a translucent white cup into their mouths. "When I breathed it in, it tasted a bit sweet.” …

Afraid of needles? China using inhalable COVID-19 vaccine
2 years, 1 month ago

Afraid of needles? China using inhalable COVID-19 vaccine

Associated Press  

BEIJING — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first. The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social media account. Chinese regulators …

China launches an inhalable COVID-19 vaccine in an apparent world first
2 years, 1 month ago

China launches an inhalable COVID-19 vaccine in an apparent world first

LA Times  

Residents of Beijing wait to get their routine coronavirus throat swabs at a testing site Tuesday. China’s biggest city, Shanghai, started administering an inhalable COVID-19 vaccine Wednesday in what appears to be a world first. Chinese regulators approved the inhalable one in September, but only as a booster shot after studies showed it triggered an immune system response in people …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light
2 years, 3 months ago

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Hindustan Times  

Bharat Biotech's Covid-19 nasal vaccine was cleared for use in adults on Tuesday. The BBV154 intranasal vaccine received emergency use authorisation from the Drugs Controller General of India after it was proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. BBV154 is believed to produce local antibodies in the upper respiratory tract which may provide the …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 3 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

China Approves World's First Inhalable Covid-19 Vaccine
2 years, 3 months ago

China Approves World's First Inhalable Covid-19 Vaccine

News 18  

Chinese drug regulators have approved the world’s first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company’s share price by seven percent on Monday. The National Medical Products Administration gave the go-ahead for the vaccine for emergency use as a booster, the company said in a statement to the Hong Kong Stock Exchange on Sunday. Scientists in …

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month
2 years, 4 months ago

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month

The Hindu  

Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of the company, Krishna Ella said. Clinical trials of nasal vaccine complete Mr. Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no instance …

Nasal Sprays Will Be Essential to Tackle Covid-19 Variants, Study Says
2 years, 5 months ago

Nasal Sprays Will Be Essential to Tackle Covid-19 Variants, Study Says

News 18  

Intranasal vaccines for COVID-19 will be critical to protect people against the emerging variants of concern of the SARS-CoV-2 virus, according to a study. “Our data showed that mRNA vaccination also did not induce sufficient tissue-residing cellular immunity in the airways, another arm of our immune system to prevent the entry of the virus into our bodies,” he added. “The …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Inhaled vaccine to be more effective
2 years, 6 months ago

Inhaled vaccine to be more effective

The Hindu  

A multidisciplinary team from the McMaster University, Toronto is working to make inhaled vaccines a reality. Fiona Smaill, Professor of Pathology and Molecular Medicine, McMaster University, and a part of the multidisciplinary team, said that they are testing a next-generation COVID-19 vaccine that the earlier research in animals suggests will last longer, will be more effective and stand up well …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 6 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

WHO clears China’s CanSino Covid vaccine for emergency use
2 years, 7 months ago

WHO clears China’s CanSino Covid vaccine for emergency use

Hindustan Times  

The World Health Organisation on Thursday granted an emergency use authorisation for Chinese manufacturer CanSinBIO’s Convidecia Covid-19 vaccine, the third Chinese vaccine to be granted such clearance. “Today, the WHO issued an emergency use listing for Convidecia, a vaccine manufactured by CanSino Biologics, China, adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19 caused …

With old-school technology, can Novavax win over COVID vaccine skeptics?
2 years, 7 months ago

With old-school technology, can Novavax win over COVID vaccine skeptics?

LA Times  

A vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London. Some people “may prefer tried and true technologies” for COVID-19 vaccines, said Dr. Filip Dubovsky, the chief medical officer of Novavax. It’s even possible a single Novavax shot could target multiple coronavirus variants in one shot, although Dubovsky said it makes …

The AP Interview: US ‘vulnerable’ to COVID without new shots
2 years, 7 months ago

The AP Interview: US ‘vulnerable’ to COVID without new shots

Associated Press  

WASHINGTON — White House COVID-19 coordinator Dr. Ashish Jha issued a dire warning Thursday that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn’t swiftly approve new funding for more vaccines and treatments. “That leaves a lot of us vulnerable.” Jha predicted that the next generation of vaccines, which are likely to be …

China's zero Covid tolerance strategy fails! Vaccine efficacy under scanner as record cases surface
2 years, 8 months ago

China's zero Covid tolerance strategy fails! Vaccine efficacy under scanner as record cases surface

India TV News  

Highlights China's Zero Covid Policy is proving to be a failure as record cases still surface This situation is when China is one of the top 5 countries to administer maximum number of jabs Questions are also being raised on the efficacy of its Covid vaccine Covid situation is once again going out of hands in China which has been …

Better to err on the side of caution to ensure public health during pandemic, TN tells SC
2 years, 9 months ago

Better to err on the side of caution to ensure public health during pandemic, TN tells SC

The Hindu  

States like Tamil Nadu and Maharashtra in the Supreme Court on Tuesday justified their hardened stand to make COVID-19 inoculation mandatory, even at the cost of denying people their rights, by saying that it was better to err on the side of caution to prevent serious or irreversible harm to the public when there was insufficient information about the virus. …

China takes strict, swift measures to stem new COVID-19 infections
2 years, 9 months ago

China takes strict, swift measures to stem new COVID-19 infections

China Daily  

BEIJING -- China is taking strict and swift measures to stem new COVID-19 infections that have emerged in multiple regions recently. The Chinese mainland on Saturday reported 1,807 locally transmitted COVID-19 cases in 19 provincial-level regions, the National Health Commission said Sunday. In Northeast China's Jilin province, which reported 1,412 local cases Saturday, local authorities have conducted multiple rounds of …

China takes strict, swift measures to stem new COVID-19 infections
2 years, 9 months ago

China takes strict, swift measures to stem new COVID-19 infections

China Daily  

BEIJING -- China is taking strict and swift measures to stem new COVID-19 infections that have emerged in multiple regions recently. The Chinese mainland on Saturday reported 1,807 locally transmitted COVID-19 cases in 19 provincial-level regions, the National Health Commission said Sunday. In Northeast China's Jilin province, which reported 1,412 local cases Saturday, local authorities have conducted multiple rounds of …

Canada authorises first plant-based COVID-19 vaccine
2 years, 10 months ago

Canada authorises first plant-based COVID-19 vaccine

India Today  

Canadian regulators said Thursday Medicago's two-dose vaccine can be given to adults ages 18 to 64, but said there's too little data on the shots in people 65 and older. The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 — although that was before the omicron variant emerged. While …

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech
2 years, 10 months ago

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech

Firstpost  

The FDA has lifted its clinical hold on Bharat Biotech’s Investigational New Drug application to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States Hyderabad: Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States. “Ocugen, Inc announced that the US Food …

Real-world data shows domestic vaccines effective against new variants
2 years, 10 months ago

Real-world data shows domestic vaccines effective against new variants

China Daily  

People receive COVID-19 vaccines at a temporary vaccination site in Nan'an district of Chongqing, Southwest China, March 27, 2021. Real-world studies in China have shown domestic COVID-19 vaccines are effective in reducing severe cases and deaths against the Delta and Omicron variants, a leading health expert said on Saturday. Shao Yiming, a member of the country's vaccine development expert panel, …

China's most used COVID shots effective against Delta variant: study
2 years, 10 months ago

China's most used COVID shots effective against Delta variant: study

China Daily  

BEIJING - China's two most widely used COVID-19 vaccines, developed by Sinovac and Sinopharm, were shown to be effective against the Delta variant of the coronavirus, a study based on real-world data in the country showed on Tuesday. The study did not generate sufficient data to deliver effectiveness readings for the two vaccines separately or by age groups, researchers from …

Two years on, vaccines and following protocols remain most effective weapons against COVID-19
2 years, 10 months ago

Two years on, vaccines and following protocols remain most effective weapons against COVID-19

India TV News  

Highlights India completes two years since the outbreak of Covid was first reported India has witnessed three waves of COVID-19 since Jan 2020 No definitive treatment has emerged as yet As India completed two years since the outbreak of COVID-19, vaccines and following COVID Appropriate Behaviour remain the most effective weapons against the deadly virus. Health Minister Mansukh Mandaviya on …

Production of one-dose vaccine starts in Shanghai
2 years, 10 months ago

Production of one-dose vaccine starts in Shanghai

China Daily  

A medical worker administers a booster shot of COVID-19 vaccine to a local resident at a temporary vaccination site in Beijing, Nov 29, 2021. The production of a single-shot COVID-19 vaccine made by CanSino SPH Biologics Inc, the first novel coronavirus vaccine producer in Shanghai, was launched in the city on Thursday. "The vaccine, named Convidecia, is the only single-dose …

Covid-19: What will it take to vaccinate the world?
2 years, 11 months ago

Covid-19: What will it take to vaccinate the world?

Hindustan Times  

This is one of a series of interviews by Bloomberg Opinion columnists on how to solve the world’s most pressing policy challenges. It will not provide very durable protection Clara Ferreira Marques: You’re a veteran advocate for global health, vaccines and tropical-disease control, and served as a U.S. science envoy during the Obama administration. The Texas Children’s Hospital Center for …

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India
2 years, 11 months ago

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India

Firstpost  

The vaccine uses an older recombinant protein yeast fermentation technology similar to that used for the recombinant hepatitis B vaccine which has been around for 40 years. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant,” said Dr Peter Hotez, professor and dean of …

How-to China: New antibody drug to boost COVID fight
3 years ago

How-to China: New antibody drug to boost COVID fight

China Daily  

A member of the research team is seen at work. Q: Will we gain more market approvals beyond China to make greater contribution to the global battle against COVID-19? After entering the phase one clinical trial in China, we conducted phase two and phase three clinical trials in areas with high COVID-19 prevalence as the epidemic had been basically brought …

How-to China: New antibody drug to boost COVID fight
3 years ago

How-to China: New antibody drug to boost COVID fight

China Daily  

A member of the research team is seen at work. Q: Will we gain more market approvals beyond China to make greater contribution to the global battle against COVID-19? After entering the phase one clinical trial in China, we conducted phase two and phase three clinical trials in areas with high COVID-19 prevalence as the epidemic had been basically brought …

How-to China: New antibody drug to boost COVID fight
3 years ago

How-to China: New antibody drug to boost COVID fight

China Daily  

Editor's Note: The eyes of the world are turning to China. Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease. In an exclusive interview with China Daily, Zhang Linqi, leader of the research team and director of the …

UK scientists trial first needle-free air-powered COVID-19 vaccine
3 years ago

UK scientists trial first needle-free air-powered COVID-19 vaccine

Live Mint  

Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19. "It’s vital that we continue to develop new generation vaccine candidates ready to help keep us safe from the next virus threats. Immunisation arms our immune system to look out for and block …

Discover Related